Directory
Rosa Maria Marti Laborda

Rosa Maria Marti Laborda

Degree: PhD

973 70 52 38
marti(ELIMINAR)@medicina.udl.cat

ResearcherID: http://www.researcherid.com/rid/A-2256-2010

Groups

Publications

  • Rodriguez-Hernandez I; Maiques O; Kohlhammer L; Cantelli G; Perdrix-Rosell A; Monger J; Fanshawe B; Bridgeman VL; Karagiannis SN; Penin RM; Marcolval J; Marti RM; Matias-Guiu X; Fruhwirth GO; Orgaz JL; Malanchi I; Sanz-Moreno V

    WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.

    Nature Communications 11 5315-5315. .

    [doi:10.1038/s41467-020-18951-2]

  • López-Cano C; Gutiérrez-Carrasquilla L; Barbé F; Sánchez E; Hernández M; Martí R; Ceperuelo-Mallafre V; Dalmases M; Fernández-Veledo S; Vendrell J; Hernández C; Simó R; Lecube A

    Effect of Type 2 Diabetes Mellitus on the Hypoxia-Inducible Factor 1-Alpha Expression. Is There a Relationship with the Clock Genes?

    Journal of Clinical Medicine 9 1-10. .

    [doi:10.3390/jcm9082632]

  • Lopez-Martin, JA; Fernandez, AA; Rios-Martin, JJ; Hernandez-Losa, J; Hernandez, LA; Fuentes, PC; Reina, SO; Izquierdo, EO; Marti, RM; Garcia, JS; Fabrega, BF; Peralto, JLR

    Frequency and Clinicopathological Profile Associated with BrafMutations in Patients with Advanced Melanoma in Spain

    Translational Oncology 13 -. .

    [doi:10.1016/j.tranon.2020.100750]

  • Moreno, S; Maiques, O; Gatius, S; Vea, A; Barrera, J; Barcelo, C; Santacana, M; Soria, X; Matias-Guiu, X; Marti, RM

    Descriptive study of naevus involution in a series of 74 patients with atypical naevus syndrome under SIAscopy digital follow-up

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 34 1210-1217. .

    [doi:10.1111/jdv.16084]

  • Sanchez, E; Mizab, C; Sauret, A; Barbe, F; Marti, R; Lopez-Cano, C; Hernandez, M; Gutierrez-Carrasquilla, L; Carmona, P; Gonzalez, J; Dalmases, M; Hernandez, C; Simo, R; Lecube, A

    Effect of Subcutaneous Insulin on Spirometric Maneuvers in Patients with Type 1 Diabetes: A Case-Control Study.

    Journal of Clinical Medicine 9 -. .

    [doi:10.3390/jcm9051249]

  • Fernandez-de-Misa, R; Hernandez-Machin, B; Combalia, A; García Muret MP; Servitje, O; Muniesa, C; Gallardo, F; Pujol, RM; Marti, RM; Ortiz-Brugues, A; Maroñas-Jiménez L; Ortiz-Romero, PL; Blanch Rius L; Izu, R; Roman, C; Cañueto J; Blanes, M; Morillo, M; Bastida, J; Peñate Y; Pérez Gala S; Espinosa Lara P; Pérez Gil A; Estrach, T

    Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 34 762-768. .

    [doi:10.1111/jdv.16006]

  • Barcelo, C; Siso, P; Maiques, O; de la Rosa, I; Marti, RM; Macia, A

    T-type calcium channels: A potential novel target in melanoma

    Cancers 12 -. .

    [doi:10.3390/cancers12020391]

  • Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet, X; Matias-Guiu, X; Marti, RM; Macia, A

    T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF V600E melanoma: TTCCs are therapy target in BRAF V600E melanoma.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 140 1253-1265. .

    [doi:10.1016/j.jid.2019.11.014]

  • Pijuan, J; Barcelo, C; Moreno, DF; Maiques, O; Siso, P; Marti, RM; Macia, A; Panosa, A

    In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis

    Frontiers In Cell And Developmental Biology 7 107-107. .

    [doi:10.3389/fcell.2019.00107]

  • Matas-Nadal, C; Malvehy, J; Ferreres, JR; Boada, A; Bodet, D; Segura, S; Salleras, M; Azon, A; Bel-Pla, S; Bigata, X; Campoy, A; Curco, N; Dalmau, J; Formigon, M; Gonzalez, A; Just, M; Llistosella, E; Nogues, ME; Pedragosa, R; Pujol, JA; Sabat, M; Smandia, JA; Zaballos, P; Puig, S; Marti, RM

    Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia

    International journal of dermatology 58 577-581. .

    [doi:10.1111/ijd.14334]

  • Georgouli, M; Herraiz, C; Crosas-Molist, E; Fanshawe, B; Maiques, O; Perdrix, A; Pandya, P; Rodriguez-Hernandez, I; Ilieva, KM; Cantelli, G; Karagiannis, P; Mele, S; Lam, H; Josephs, DH; Matias-Guiu, X; Marti, RM; Nestle, FO; Orgaz, JL; Malanchi, I; Fruhwirth, GO; Karagiannis, SN; Sanz-Moreno, V

    Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment

    Cell 176 757-77423. .

    [doi:10.1016/j.cell.2018.12.038]

  • Lopez-Lerma, I; Peñate Y; Gallardo, F; Marti, RM; Mitxelena, J; Bielsa, I; Velasco-Tamariz, V; Yanguas-Bayona, JI; Sanchez-Sambucety, P; Garcia-Patos, V; Ortiz-Romero, PL; Pujol, RM; Estrach, T

    Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 79 892-898. .

    [doi:10.1016/j.jaad.2018.05.1243]

Projects

  • Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
  • EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
  • UNA FLOR PER A UN PROJECTE: ESTUDI DE DOS FARMACS PEL TRACTAMENT DEL MELANOMA
  • GOTTA - ALTERACIONS MOLECULARS DEL MELANOMA
  • Efecto de los inhib idores del proteasoma en células de melanoma